C12Y 207/1103
Receptor protein serine/threonine kinase
Official title: Receptor protein serine/threonine kinase (2.7.11.30)
C12Y207/1103 (Receptor protein serine/threonine kinase) appears on 50 US grants and 96 published applications in this corpus.
Search patents in C12Y- Granted patents
- 50
- Published applications
- 96
- Assignees
- 15
- Inventors
- 86
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 3 |
| 2010 | 2 | 5 |
| 2011 | 2 | 1 |
| 2012 | 3 | 2 |
| 2013 | 2 | 7 |
| 2014 | 1 | 1 |
| 2015 | 3 | 2 |
| 2016 | 4 | 9 |
| 2017 | 2 | 6 |
| 2018 | 1 | 5 |
| 2019 | 6 | 7 |
| 2020 | 0 | 11 |
| 2021 | 11 | 3 |
| 2022 | 2 | 8 |
| 2023 | 3 | 5 |
| 2024 | 2 | 8 |
| 2025 | 3 | 9 |
| 2026 | 2 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Bifunctional antagonists of activin and tumor necrosis factor alpha and uses thereof11 Aug 2026US 12,703,742 B2
- Activin receptor type IIA variants and methods of use thereof24 Mar 2026US 12,582,700 B2Keros Therapeutics, Inc.
- RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), compositions thereof, and methods of use14 Oct 2025US 12,442,002 B2Arrowhead Pharmaceuticals, Inc.
- Activin receptor type IIa variants and methods of use thereof8 Jul 2025US 12,350,313 B2Keros Therapeutics, Inc.
- Activin receptor type IIB variants and methods of use thereof8 Apr 2025US 12,269,858 B2Keros Therapeutics, Inc.
- Gene editing systems and methods for reducing immunogenicity and graft versus host response4 Jun 2026US 2026/0152740 A1Correctsequence Therapeutics (Shanghai) Co., Ltd
- RNAi Agents for Inhibiting Expression of Activin Receptor-Like Kinase 7 (ALK7), Compositions Thereof, and Methods of Use14 May 2026US 2026/0132406 A1Arrowhead Pharmaceuticals, Inc.
- Anti-alk-1 antibody and use thereof18 Dec 2025US 2025/0382386 A1Kintor Pharmaceutical (Guangdong) Co., Ltd
- Solanaceous plant resistant to virus of genus begomovirus causing tomato yellow leaf curl symptoms, solanaceous plant cell, and method for producing solanaceous plant16 Oct 2025US 2025/0320517 A1Kikkoman Corporation
- Activin receptor type iia variants and methods of use thereof25 Sep 2025US 2025/0295735 A1Keros Therapeutics, Inc.
Most cited
By later US patents
- ActRII receptor polypeptides, methods and compositions121US 7,709,605 B2Acceleron Pharma Inc. · 2010
- Method of increasing red blood cell levels or treating anemia in a patient94US 8,058,229 B2Acceleron Pharma Inc. · 2011
- Actriib-Fc polynucleotides, polypeptides, and compositions83US 8,252,900 B2Acceleron Pharma Inc. · 2012
- Isolated nucleic acid encoding a truncated ActRIIB fusion protein74US 8,293,881 B2Acceleron Pharma Inc. · 2012
- Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion46US 7,960,343 B2Acceleron Pharma Inc. · 2011